Salsalate attenuates free fatty acid-induced microvascular and metabolic insulin resistance in humans

Diabetes Care

Volumn 34, Issue 7, 2011, Pages 1634-1638

  Chai, Weidong ^a   Liu, Jia ^a   Jahn, Linda A ^a   Fowler, Dale E ^a   Barrett, Eugene J ^a   Liu, Zhenqi ^a  

^a UNIVERSITY OF VIRGINIA HEALTH SYSTEM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FATTY ACID; GLUCOSE; INSULIN; SALSALATE; PHOSPHOLIPID; SALICYLIC ACID DERIVATIVE; SOYBEAN OIL; SOYBEAN OIL, PHOSPHOLIPID EMULSION;

ADULT; ANTIINFLAMMATORY ACTIVITY; ARTICLE; BLOOD FLOW VELOCITY; BLOOD VOLUME; CONTROLLED STUDY; DRUG BLOOD LEVEL; DRUG MECHANISM; DRUG TOLERABILITY; FATTY ACID BLOOD LEVEL; FEMALE; GLUCOSE BLOOD LEVEL; HUMAN; HUMAN EXPERIMENT; INFLAMMATION; INSULIN BLOOD LEVEL; INSULIN LIKE ACTIVITY; INSULIN RESPONSE; MALE; METABOLIC REGULATION; METABOLIC SYNDROME X; MICROVASCULATURE; NORMAL HUMAN; TREATMENT OUTCOME; BLOOD; DRUG EFFECT; EMULSION; GLUCOSE CLAMP TECHNIQUE; HEART MUSCLE; INSULIN RESISTANCE; MICROCIRCULATION; PHYSIOLOGY; SKELETAL MUSCLE; VASCULARIZATION;

EMULSIONS; FATTY ACIDS, NONESTERIFIED; FEMALE; GLUCOSE CLAMP TECHNIQUE; HUMANS; INSULIN RESISTANCE; MALE; MICROCIRCULATION; MUSCLE, SKELETAL; MYOCARDIUM; PHOSPHOLIPIDS; SALICYLIC ACIDS; SOYBEAN OIL; YOUNG ADULT;

EID: 80054699764     PISSN: 01495992     EISSN: 19355548     Source Type: Journal    
DOI: 10.2337/dc10-2345     Document Type: Article

References (22)

1. Kim F, Tysseling KA, Rice J, et al. Free fatty acid impairment of nitric oxide production in endothelial cells ismediated by IKKbeta. Arterioscler Thromb Vasc Biol 2005;25:989-994 (Pubitemid 40627844)
2. Arkan MC, Hevener AL, Greten FR, et al. IKK-β links inflammation to obesity-induced insulin resistance. Nat Med 2005;11:191-198 (Pubitemid 40321355)
3. Shoelson SE, Lee J, Goldfine AB. Inflammation and insulin resistance. J Clin Invest 2006;116:1793-1801 (Pubitemid 44033299)
4. Kim JK, Kim Y-J, Fillmore JJ, et al. Prevention of fat-induced insulin resistance by salicylate. J Clin Invest 2001;108:437-446 (Pubitemid 32730790)
5. Liu Z. Insulin at physiological concentrations increases microvascular perfusion in human myocardium. Am J Physiol Endocrinol Metab 2007;293:E1250-E1255 (Pubitemid 350106591)
6. Liu J, Jahn LA, Fowler DE, Barrett EJ, Cao W, Liu Z. Free fatty acids induce insulin resistance in both cardiac and skeletal muscle microvasculature in humans. J Clin Endocrinol Metab 2011;96:438-446
7. Liu Z, Liu J, Jahn LA, Fowler DE, Barrett EJ. Infusing lipid raises plasma free fatty acids and induces insulin resistance in muscle microvasculature. J Clin Endocrinol Metab 2009;94:3543-3549
8. Barrett EJ, Eggleston EM, Inyard AC, et al. The vascular actions of insulin control its delivery to muscle and regulate the rate-limiting step in skeletal muscle insulin action. Diabetologia 2009;52:752-764
9. Clerk LH, Rattigan S, Clark MG. Lipid infusion impairs physiologic insulin-mediated capillary recruitment and muscle glucose uptake in vivo. Diabetes 2002;51:1138-1145 (Pubitemid 34438361)
10. Yin M-J, Yamamoto Y, Gaynor RB. The anti-inflammatory agents aspirin and salicylate inhibit the activity of I(κ)B kinase-β. Nature 1998;396:77-80 (Pubitemid 28520452)
11. Carvalho-Filho MA, Ropelle ER, Pauli RJ, et al. Aspirin attenuates insulin resistance in muscle of diet-induced obese rats by inhibiting inducible nitric oxide synthase production and S-nitrosylation of IRbeta/IRS-1 and Akt. Diabetologia 2009;52:2425-2434
12. Yuan M, Konstantopoulos N, Lee J, et al. Reversal of obesity- and diet-induced insulin resistance with salicylates or targeted disruption of Ikkbeta. Science 2001;293:1673-1677 (Pubitemid 32807849)
13. Fleischman A, Shoelson SE, Bernier R, Goldfine AB. Salsalate improves glycemia and inflammatory parameters in obese young adults. Diabetes Care 2008;31:289-294 (Pubitemid 351213338)
14. Koska J, Ortega E, Bunt JC, et al. The effect of salsalate on insulin action and glucose tolerance in obese non-diabetic patients: results of a randomised double-blind placebo-controlled study. Diabetologia 2009;52:385-393
15. Goldfine AB, Fonseca V, Jablonski KA, Pyle L, Staten MA, Shoelson SE; TINSAL-T2D (Targeting Inflammation Using Salsalate in Type 2 Diabetes) Study Team. The effects of salsalate on glycemic control in patients with type 2 diabetes: a randomized trial. Ann Intern Med 2010;152:346-357
16. Tripathy D, Mohanty P, Dhindsa S, et al. Elevation of free fatty acids induces inflammation and impairs vascular reactivity in healthy subjects. Diabetes 2003;52:2882-2887 (Pubitemid 37466856)
17. Steinberg HO, Paradisi G, Hook G, Crowder K, Cronin J, Baron AD. Free fatty acid elevation impairs insulin-mediated vasodilation and nitric oxide production. Diabetes 2000;49:1231-1238 (Pubitemid 30439100)
18. Steinberg HO, Tarshoby M, Monestel R, et al. Elevated circulating free fatty acid levels impair endothelium-dependent vasodilation. J Clin Invest 1997;100:1230-1239 (Pubitemid 27386309)
19. Dresner A, Laurent D, Marcucci M, et al. Effects of free fatty acids on glucose transport and IRS-1-associated phosphatidylinositol 3-kinase activity. J Clin Invest 1999;103:253-259 (Pubitemid 29053143)
20. Aljada A, Dandona P. Effect of insulin on human aortic endothelial nitric oxide synthase. Metabolism2000;49:147-150 (Pubitemid 30090874)
21. Nolan JJ, Ludvik B, Baloga J, Reichart D, Olefsky JM. Mechanisms of the kinetic defect in insulin action in obesity and NIDDM. Diabetes 1997;46:994-1000 (Pubitemid 27221000)
22. Fernández-Real J-M, López-Bermejo A, Ropero A-B, et al. Salicylates increase insulin secretion in healthy obese subjects. J Clin Endocrinol Metab 2008;93:2523-2530 (Pubitemid 352008516)